Ultra-Processed Food Consumption and Irritable Bowel Syndrome: Current Evidence and Clinical Implications
Nutrients · 14.11.2025 · 17 (22) · 3567
DOI: 10.3390/nu17223567 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 14.11.2025. Verfasst von Hanna Fjeldheim Dale und 2 weiteren Autor:innen. Beteiligte Einrichtung: Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, 0456 Oslo, Norway. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Fast Foods, Diet, Food Handling. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Irritable bowel syndrome (IBS) is a prevalent disorder of gut–brain interaction (DGBI) with an adverse impact on quality of life. The global consumption of ultra-processed foods (UPF) is rapidly increasing, and UPF intake has recently been linked to a wide range of metabolic and chronic diseases. The potential role of UPF consumption in the onset and symptom generation of IBS is emerging but remains unclear. This narrative review synthesizes epidemiological evidence on the association between UPF consumption and IBS, integrates mechanistic insights from experimental and clinical studies and suggests clinical implications based on the current state of knowledge. Observational studies suggest that higher UPF intake may be associated with increased risk of IBS, although the evidence base is limited and subject to methodological challenges. Mechanistic studies indicate that additives including emulsifiers and non-nutritive sweeteners can alter pathways relevant to IBS symptom generation, such as gut microbiota composition, impair intestinal barrier function and trigger low-grade inflammation. Current evidence supports a possible link between UPF consumption and IBS. Increasing overall dietary quality and reducing UPF intake are promising complementary strategies to established dietary interventions. Future intervention trials may provide insights into relevant biological mechanisms, particularly if such changes co-occur with symptom improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unger-Vetlesen Institute, Lovisenberg Diaconal Hospital, 0456 Oslo, Norway.
- Department of Health, Oslo New University College, 0454 Oslo, Norway.
- Institute of Clinical Medicine, University of Oslo, 0372 Oslo, Norway.
ORCID-Profile: Hanna Fjeldheim Dale, Marit Kolby, Jørgen Valeur
Zitieren
APA
Dale, H. F., Kolby, M., & Valeur, J. (2025). Ultra-Processed Food Consumption and Irritable Bowel Syndrome: Current Evidence and Clinical Implications. Nutrients, 17(22), 3567. https://doi.org/10.3390/nu17223567
Vancouver
Dale HF, Kolby M, Valeur J. Ultra-Processed Food Consumption and Irritable Bowel Syndrome: Current Evidence and Clinical Implications. Nutrients. 2025;17(22):3567. doi:10.3390/nu17223567
BibTeX
@article{Dale2025,
author = {Dale, Hanna Fjeldheim and Kolby, Marit and Valeur, Jørgen},
title = {Ultra-Processed Food Consumption and Irritable Bowel Syndrome: Current Evidence and Clinical Implications},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {22},
pages = {3567},
doi = {10.3390/nu17223567}
}
EUVIMED